Document Type : Original Article


Personalized Medicine Research Center of AmitisGen, Tehran, Iran



Numerous studies have been conducted to investigate the relationship between genetic factors and drug use tendency, many of which have shown a significant correlation between genetic factors and drug use, especially heroin and cocaine. The most important site of drug action is the brain, which contains a variety of nerve receptors. Dynorphins are opioid peptides derived from the prodynorphins precursor (PDYN). These opioid peptides are capable of binding to the three types of opioid receptors. Studies have shown that heroin and cocaine use is associated with increased PDYN gene expression in specific areas of the brain. In this study, we investigated the association between rs910080 polymorphism in the 3'UTR region and the number of VNTR sequences in the promoter region with the tendency of heroin use in 155heroin addicts and 150 control with RFLP method. Results showed a significant relationship between heroin abuse and CC genotype in rs910080 polymorphism (P = 0.001), but no significant relationship between VNTR promoter repeats and heroin abuse. Rs910080 polymorphism can be used as a distinguishing factor.


1. Wang CW, Ma M, Lu WG, Luo RQ. Association between
prodynorphin gene polymorphisms and opioid dependence
susceptibility: a meta-analysis. BMC Psychiatry.
2019;19(1):281. doi: 10.1186/s12888-019-2272-7 pmid:
2. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E,
Rotrosen J, et al. Genetic susceptibility to heroin addiction: a
candidate gene association study. Genes Brain Behav.
2008;7(7):720-729. doi: 10.1111/j.1601-183X.2008.00410.x
pmid: 18518925
3. Nutt DJ. Addiction: brain mechanisms and their treatment
implications. Lancet. 1996;347(8993):31-36. doi:
10.1016/s0140-6736(96)91561-5 pmid: 8531549
4. Hall FS, Goeb M, Li XF, Sora I, Uhl GR. mu-Opioid receptor
knockout mice display reduced cocaine conditioned place
preference but enhanced sensitization of cocaine-induced
locomotion. Brain Res Mol Brain Res. 2004;121(1-2):123-130.
doi: 10.1016/j.molbrainres.2003.10.024 pmid: 14969743
5. Yirmiya R, Taylor AN. Genetic differences in opiate receptor
concentration and sensitivity to ethanol's effects. Pharmacol
Biochem Behav. 1989;33(4):793-796. doi: 10.1016/0091-
3057(89)90472-3 pmid: 2559415
6. Adinoff B. Neurobiologic processes in drug reward and
addiction. Harv Rev Psychiatry. 2004;12(6):305-320. doi:
10.1080/10673220490910844 pmid: 15764467
7. Wei SG, Zhu YS, Lai JH, Xue HX, Chai ZQ, Li SB. Association
between heroin dependence and prodynorphin gene
polymorphisms. Brain Res Bull. 2011;85(3-4):238-242. doi:
10.1016/j.brainresbull.2011.02.010 pmid: 21382455
8. Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH,
Kampman KM, Dackis CA, et al. Genetic association analyses
of PDYN polymorphisms with heroin and cocaine addiction.
Genes Brain Behav. 2012;11(4):415-423. doi: 10.1111/j.1601-
183X.2012.00785.x pmid: 22443215
9. Saify K, Saadat I, Saadat M. Association between VNTR
polymorphism in promoter region of prodynorphin (PDYN)
gene and heroin dependence. Psychiatry Res.
2014;219(3):690-692. doi: 10.1016/j.psychres.2014.06.048
pmid: 25048760
10. Nikoshkov A, Drakenberg K, Wang X, Horvath MC, Keller E,
Hurd YL. Opioid neuropeptide genotypes in relation to heroin
abuse: dopamine tone contributes to reversed mesolimbic
proenkephalin expression. Proc Natl Acad Sci U S A.
2008;105(2):786-791. doi: 10.1073/pnas.0710902105
pmid: 18184800
11. Hashemi M, Shakiba M, Sanaei S, Shahkar G, Rezaei M,
Mojahed A, et al. Evaluation of prodynorphin gene
polymorphisms and their association with heroin addiction in
a sample of the southeast Iranian population. Mol Biol Res
Commun. 2018;7(1):1-6. doi:
10.22099/mbrc.2017.27182.1294 pmid: 29911117
12. Yuferov V, Ji F, Nielsen DA, Levran O, Ho A, Morgello S, et al.
A functional haplotype implicated in vulnerability to develop
cocaine dependence is associated with reduced PDYN
expression in human brain. Neuropsychopharmacology.
2009;34(5):1185-1197. doi: 10.1038/npp.2008.187 pmid: